Literature DB >> 15164304

Apoptosis in human uterine leiomyomas.

Kristina M Martel1, Angela C Ko, Gregory M Christman, John M Stribley.   

Abstract

Human uterine leiomyomas (fibroids) are benign neoplasms that typically occur in reproductive age and perimenopausal women. These tumors pose a significant and costly health concern for numerous women throughout the world. Alternative therapies are few, with hysterectomy being the treatment of choice by many physicians. There is a growing body of evidence suggesting that the development of leiomyomas may be influenced by numerous factors including genetic, environmental, and hormonal influences resulting in a possible failure of any number of apoptotic pathways. Understanding the role apoptosis plays in the normal regression of nascent myometrial tissue and how this failure may influence leiomyoma tumor growth may provide a better understanding of how to develop effective and less invasive treatment modalities for this disease. The following review attempts to highlight what is currently known about apoptosis in leiomyomas as compared with the normal myometrium and where future research is needed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15164304     DOI: 10.1055/s-2004-828615

Source DB:  PubMed          Journal:  Semin Reprod Med        ISSN: 1526-4564            Impact factor:   1.303


  9 in total

1.  1,25-dihydroxyvitamin D3 treatment shrinks uterine leiomyoma tumors in the Eker rat model.

Authors:  Sunil K Halder; Chakradhari Sharan; Ayman Al-Hendy
Journal:  Biol Reprod       Date:  2012-04-19       Impact factor: 4.285

2.  Activating transcription factor 3 gene expression suggests that tissue stress plays a role in leiomyoma development.

Authors:  Mark Payson; Minnie Malik; Sarah Siti-Nur Morris; James H Segars; Rebecca Chason; William H Catherino
Journal:  Fertil Steril       Date:  2008-08-09       Impact factor: 7.329

3.  Endometriosis expresses a molecular pattern consistent with decreased retinoid uptake, metabolism and action.

Authors:  Mary Ellen Pavone; Matthew Dyson; Scott Reirstad; Elizabeth Pearson; Hiroshi Ishikawa; You Hong Cheng; Serdar E Bulun
Journal:  Hum Reprod       Date:  2011-06-08       Impact factor: 6.918

4.  Analysis of the in vitro effects of di-(2-ethylhexyl) phthalate exposure on human uterine leiomyoma cells.

Authors:  Jin Hee Kim
Journal:  Exp Ther Med       Date:  2018-04-10       Impact factor: 2.447

Review 5.  The expression and potential regulatory function of microRNAs in the pathogenesis of leiomyoma.

Authors:  Xiaoping Luo; Nasser Chegini
Journal:  Semin Reprod Med       Date:  2008-10-24       Impact factor: 1.303

6.  Nanomedicine for uterine leiomyoma therapy.

Authors:  Hazem Ali; Gokhan Kilic; Kathleen Vincent; Massoud Motamedi; Erik Rytting
Journal:  Ther Deliv       Date:  2013-02

7.  A High Concentration of Genistein Induces Cell Death in Human Uterine Leiomyoma Cells by Autophagy.

Authors:  Lysandra Castro; Xioahua Gao; Alicia B Moore; Linda Yu; Xudong Di; Grace E Kissling; Darlene Dixon
Journal:  Expert Opin Environ Biol       Date:  2016-05-30

Review 8.  The Role of Tumor Necrosis Factor α in the Biology of Uterine Fibroids and the Related Symptoms.

Authors:  Michał Ciebiera; Marta Włodarczyk; Magdalena Zgliczyńska; Krzysztof Łukaszuk; Błażej Męczekalski; Christopher Kobierzycki; Tomasz Łoziński; Grzegorz Jakiel
Journal:  Int J Mol Sci       Date:  2018-12-04       Impact factor: 5.923

9.  Effect of a selective progesterone receptor modulator on induction of apoptosis in uterine fibroids in vivo.

Authors:  Petr Horak; Michal Mara; Pavel Dundr; Kristyna Kubinova; David Kuzel; Robert Hudecek; Roman Chmel
Journal:  Int J Endocrinol       Date:  2012-07-16       Impact factor: 3.257

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.